Is there an association between lipid-lowering drugs and cholecystectomy?
- 1 April 2000
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 108 (5) , 418-421
- https://doi.org/10.1016/s0002-9343(99)00452-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bileGastroenterology, 1998
- Prevalence and Associated Factors for Gallstone Disease: Results of a Population Survey in SpainJournal of Clinical Epidemiology, 1997
- The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐upJournal of Internal Medicine, 1994
- Successful dissolution of cholesterol gallstone during treatment with pravastatinGastroenterology, 1992
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Effects of fenofibrate on biliary lipids and bile acid pool size in patients with type IV hyperlipoproteinemiaAtherosclerosis, 1985
- Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjectsMetabolism, 1985
- Gemfibrozil — The effect on biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrateAtherosclerosis, 1981
- Biliary and plasma lipids and lipid-lowering chemotherapy Studies with clofibrate, fenofibrate and etofibrate in healthy volunteersAtherosclerosis, 1980
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975